|
Volumn 8, Issue 3, 2006, Pages 213-214
|
Metabolic syndrome in patients with schizophrenia: CATIE results.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NEUROLEPTIC AGENT;
ADULT;
CHEMICALLY INDUCED DISORDER;
CROSS-SECTIONAL STUDY;
FEMALE;
HEALTH SURVEY;
HUMAN;
MALE;
METABOLIC SYNDROME X;
MIDDLE AGED;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
ADULT;
ANTIPSYCHOTIC AGENTS;
CROSS-SECTIONAL STUDIES;
FEMALE;
HEALTH SURVEYS;
HUMANS;
MALE;
METABOLIC SYNDROME X;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK FACTORS;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
|
EID: 70350445093
PISSN: 15233812
EISSN: None
Source Type: Journal
DOI: 10.1007/s11920-006-0025-z Document Type: Note |
Times cited : (1)
|
References (0)
|